Cargando…
Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release
Polymorphisms associated with BIN1 (bridging integrator 1) confer the second greatest risk for developing late-onset Alzheimer’s disease. The biological consequences of this genetic variation are not fully understood; however, BIN1 is a binding partner for tau. Tau is normally a highly soluble cytop...
Autores principales: | Glennon, Elizabeth B, Lau, Dawn H W, Gabriele, Rebecca M C, Taylor, Matthew F, Troakes, Claire, Opie-Martin, Sarah, Elliott, Christina, Killick, Richard, Hanger, Diane P, Perez-Nievas, Beatriz G, Noble, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272218/ https://www.ncbi.nlm.nih.gov/pubmed/32500121 http://dx.doi.org/10.1093/braincomms/fcaa011 |
Ejemplares similares
-
Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain
por: Kurbatskaya, Ksenia, et al.
Publicado: (2016) -
Physiological release of endogenous tau is stimulated by neuronal activity
por: Pooler, Amy M, et al.
Publicado: (2013) -
Roles of tau protein in health and disease
por: Guo, Tong, et al.
Publicado: (2017) -
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
por: Lau, Dawn H. W., et al.
Publicado: (2016) -
Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation
por: Hanger, Diane P., et al.
Publicado: (2011)